Athersys (NASDAQ:ATHX) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX) in a research report released on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.

Athersys Stock Down 33.5 %

Shares of NASDAQ:ATHX opened at $0.01 on Friday. Athersys has a one year low of $0.01 and a one year high of $1.99. The company has a market capitalization of $833,206.50, a P/E ratio of 0.00 and a beta of -0.90.

About Athersys

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.